blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2040757

EP2040757 - NEW PROTEIN CONJUGATES AND METHODS FOR THEIR PREPARATION [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  27.11.2015
Database last updated on 02.11.2024
Most recent event   Tooltip27.11.2015Withdrawal of applicationpublished on 30.12.2015  [2015/53]
Applicant(s)For all designated states
Novo Nordisk Health Care AG
Thurgauerstrasse 36/38
8050 Zürich / CH
[2013/15]
Former [2009/14]For all designated states
Novo Nordisk Health Care AG
Andreasstrasse 15
8050 Zürich / CH
Inventor(s)01 / DÖRWALD, Florencio Zaragoza
Bäretstrasse 2
CH-3930 Visp / CH
 [2009/18]
Former [2009/14]01 / DÖRWALD, Florencio Zaragoza
No̸ddelunden 22
DK-2765 Smo̸rum / DK
Representative(s)Winther, Kamilla
Novo Nordisk A/S Corporate Patents Novo Allé
2880 Bagsvaerd / DK
[2009/14]
Application number, filing date07802373.605.07.2007
[2009/14]
WO2007EP56819
Priority number, dateEP2006011677607.07.2006         Original published format: EP 06116776
[2009/14]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008003750
Date:10.01.2008
Language:EN
[2008/02]
Type: A2 Application without search report 
No.:EP2040757
Date:01.04.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 10.01.2008 takes the place of the publication of the European patent application.
[2009/14]
Search report(s)International search report - published on:EP20.03.2008
ClassificationIPC:A61K47/48, C07K14/43
[2009/14]
CPC:
C07K14/61 (EP,KR,US); A61K38/27 (KR); A61K47/60 (EP,US);
A61P13/12 (EP); A61P19/00 (EP); A61P25/30 (EP);
A61P29/00 (EP); A61P43/00 (EP); A61P5/06 (EP);
C07K1/10 (KR); C07K1/1077 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/14]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:NEUE PROTEINKONJUGATE UND HERSTELLUNGSVERFAHREN[2009/14]
English:NEW PROTEIN CONJUGATES AND METHODS FOR THEIR PREPARATION[2009/14]
French:NOUVEAUX CONJUGUÉS DE PROTÉINES ET LEURS PROCÉDÉS DE PRÉPARATION[2009/14]
Entry into regional phase09.02.2009National basic fee paid 
09.02.2009Designation fee(s) paid 
09.02.2009Examination fee paid 
Examination procedure09.02.2009Examination requested  [2009/14]
18.01.2011Despatch of a communication from the examining division (Time limit: M04)
26.04.2011Reply to a communication from the examining division
06.10.2014Despatch of a communication from the examining division (Time limit: M06)
13.04.2015Reply to a communication from the examining division
25.11.2015Application withdrawn by applicant  [2015/53]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  18.01.2011
Fees paidRenewal fee
31.07.2009Renewal fee patent year 03
02.08.2010Renewal fee patent year 04
01.08.2011Renewal fee patent year 05
31.07.2012Renewal fee patent year 06
31.07.2013Renewal fee patent year 07
31.07.2014Renewal fee patent year 08
31.07.2015Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US4179337  (DAVIS FRANK F [US], et al) [X] 1-20 * the whole document * * example XII *;
 [Y]WO9826747  (TERMAN DAVID S [US]) [Y] 1-20* page 50 *;
 [X]WO02055532  (MAXYGEN APS [DK], et al) [X] 1-20 * page 6 - page 7 *;
 [X]US6566506  (GREENWALD RICHARD B [US], et al) [X] 1-20 * columns 9,13; claim - *;
 [X]WO03044056  (PHARMACIA CORP [US], et al) [X] 1-20 * the whole document * * examples 1-17 *;
 [X]WO2005035553  (NOVO NORDISK AS [DK], et al) [X] 1-20 * page 82 - page 102 * * the whole document *;
 [Y]EP1548016  (JAPAN SCIENCE & TECH AGENCY [JP], et al) [Y] 1-20 * the whole document *;
 [Y]  - ZALIPSKY S, "FUNCTIONALIZED POLY(ETHYLENE GLYCOL) FOR PREPARATION OF BIOLOGICALLY RELEVANT CONJUGATES", BIOCONJUGATE CHEMISTRY, ACS, WASHINGTON, DC, US, (1995), vol. 6, no. 2, ISSN 1043-1802, pages 150 - 165, XP002068523 [Y] 1-20 * the whole document * * page 152, column R, paragraph L *

DOI:   http://dx.doi.org/10.1021/bc00032a002
ExaminationWO2005123140
    - QIAN Y ET AL, "Probing the hydrophobic pocket of farnesyltransferase: aromatic substitution of CAAX peptidomimetics leads to highly potent inhibitors", BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON, GB, (19991201), vol. 7, no. 12, doi:10.1016/S0968-0896(99)00252-7, ISSN 0968-0896, pages 3011 - 3024, XP002515932

DOI:   http://dx.doi.org/10.1016/S0968-0896(99)00252-7
    - Xiaoxia Wen ET AL, "Improved Radiolabeling of PEGylated Protein: PEGylated Annexin V for Noninvasive Imaging of Tumor Apoptosis", Cancer Biotherapy & Radiopharmaceuticals, (20031001), vol. 18, no. 5, doi:10.1089/108497803770418364, ISSN 1084-9785, pages 819 - 827, XP055143315

DOI:   http://dx.doi.org/10.1089/108497803770418364
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.